Approaching Summer Draws Focus on Skin Cancer Prevention
May 23rd 2018The effects of exposure to UV radiation from the sun or indoor tanning beds are cumulative, adding up over a lifetime. Advancing better UV protection has been a key goal of efforts by the healthcare community, and government agencies in recent years.
Drug Treatment Approved for Pediatric Patients with Multiple Sclerosis
May 14th 2018Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis (MS) in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.